Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Hematology

Does taking fluoroquinolone medicine help reduce high fevers in children with Acute Lymphoblastic Leukemia?

Fluoroquinolone prophylaxis reduces febrile neutropenia (fever with low white blood cells) in children with ALL, but it is not a treatment for high fevers; it is a preventive…

Hematology

Does CPX-351 improve survival for patients with Acute Myeloid Leukemia and myelodysplasia-related changes?

Yes, CPX-351 improves survival in patients with AML and myelodysplasia-related changes compared to standard chemotherapy, especially in those with AML-MR subtype.

Hematology

Does a case report show myeloid sarcoma relapse appearing in the breast for Acute Myeloid Leukemia?

Yes, a case report describes a 68-year-old woman with myeloid sarcoma relapse in the breast 6 years after initial nasal cavity presentation.

Hematology

Can Xpovio be used with dexamethasone alone for heavily pretreated relapsed Multiple Myeloma?

Yes, Xpovio (selinexor) in combination with dexamethasone alone is FDA-approved for heavily pretreated relapsed/refractory multiple myeloma after at least four prior therapies.

Hematology

Are there natural products that target the proteasome to help treat Multiple Myeloma?

Yes, natural products like lactacystin, salinosporamide A, and polyphenols can target the proteasome, but none are approved treatments for multiple myeloma; marizomib, a natural…

Hematology

Is Revlimid approved for maintenance therapy after an autologous stem cell transplant for Multiple Myeloma?

Yes, Revlimid (lenalidomide) is FDA-approved as maintenance therapy after autologous stem cell transplant for multiple myeloma.

Hematology

Can Pomalyst be used to treat Kaposi sarcoma in addition to Multiple Myeloma?

Yes, Pomalyst is FDA-approved for both multiple myeloma and Kaposi sarcoma, including AIDS-related and HIV-negative cases.

Hematology

What treatments were used in the case report for ultra-high-risk relapsed Multiple Myeloma?

The case report used a combination of ixazomib, lisaftoclax, and dexamethasone (ILD) as maintenance therapy after CAR-T cell therapy for ultra-high-risk relapsed multiple myeloma.

Hematology

Do hematologists recommend using tocilizumab with bispecific antibodies for relapsed Multiple Myeloma?

Yes, hematologists recommend using tocilizumab to manage cytokine release syndrome (CRS) caused by bispecific antibodies in relapsed/refractory multiple myeloma, including…

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.